These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 4819137
1. Development and evaluation of ointment and cream vehicles for a new topical steroid, fluclorolone acetonide. Malone T, Haleblian JK, Poulsen BJ, Burdick KH. Br J Dermatol; 1974 Feb; 90(2):187-95. PubMed ID: 4819137 [No Abstract] [Full Text] [Related]
2. The anti-infective action of a new steroid-base combination (fluclorolone acetonide in FAPG base) with conventional antimicrobial substances. Rhodes EL, Morison WL, Skinner GB, Borrett DW, Stoppard M. Curr Med Res Opin; 1972 Feb; 1(2):87-92. PubMed ID: 4589022 [No Abstract] [Full Text] [Related]
3. Clinical trial of fluclorolone acetonide in FAPG base in the treatment of varicose eczema. Henry M. Curr Med Res Opin; 1974 Feb; 2(1):27-31. PubMed ID: 4601835 [No Abstract] [Full Text] [Related]
4. Betamethasone 17-valerate ointment in a lanolin-free base. Wilson L. Curr Med Res Opin; 1973 Feb; 1(4):228-32. PubMed ID: 4589630 [No Abstract] [Full Text] [Related]
5. Inhibition of wound healing by topical steroids. Marks JG, Cano C, Leitzel K, Lipton A. J Dermatol Surg Oncol; 1983 Oct; 9(10):819-21. PubMed ID: 6619384 [Abstract] [Full Text] [Related]
6. Comparative blanching activities of proprietary diflucortolone valerate topical preparations. Coleman GL, Kanfer I, Haigh JM. Dermatologica; 1978 Oct; 156(4):224-30. PubMed ID: 342295 [Abstract] [Full Text] [Related]
7. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test. Coldman MF, Lockerbie L, Laws EA. Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552 [No Abstract] [Full Text] [Related]
8. Design of the optimal topical system for fluocinonide. Reinstein J, Ostrenga J, Haleblian J, Shastri S, Poulsen B, Katz M. Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):Suppl 67:13-8. PubMed ID: 5291642 [No Abstract] [Full Text] [Related]
9. AN IN VITRO STUDY OF THE RELATIVE MOISTURE OCCLUSIVE PROPERTIES OF SEVERAL TOPICAL VEHICLES AND SARAN WRAP. DEMPSKI RE, DEMARCO JD, MARCUS AD. J Invest Dermatol; 1965 May; 44():361-3. PubMed ID: 14292246 [No Abstract] [Full Text] [Related]
14. Diprosone ointment in psoriasis. A double-blind trial. Ross CM. S Afr Med J; 1974 Oct 05; 48(48):2030-2. PubMed ID: 4612753 [No Abstract] [Full Text] [Related]
15. Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products. Worthington HE. Acta Derm Venereol Suppl (Stockh); 1973 Oct 05; 53():29-34. PubMed ID: 4518660 [No Abstract] [Full Text] [Related]
16. Various vagaries of vasoconstriction. Burdick KH. Arch Dermatol; 1974 Aug 05; 110(2):238-42. PubMed ID: 4855376 [No Abstract] [Full Text] [Related]
17. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy. Ostrenga J, Steinmetz C, Poulsen B. J Pharm Sci; 1971 Aug 05; 60(8):1175-9. PubMed ID: 5127090 [No Abstract] [Full Text] [Related]
19. [Penetration of various labelled steroids into human skin]. Zesch A, Schaefer H. Arzneimittelforschung; 1973 Mar 05; 23(3):415-9. PubMed ID: 4740126 [No Abstract] [Full Text] [Related]
20. Antimicrobial properties of a propylene glycol based topical therapeutic agent. Olitzky I. J Pharm Sci; 1965 May 05; 54(5):787-8. PubMed ID: 5845896 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]